Skip to main content
Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
38.31
+2.83 (7.98%)
At close: Mar 9, 2026, 4:00 PM EDT
38.31
0.00 (0.00%)
After-hours: Mar 9, 2026, 6:01 PM EDT

Stoke Therapeutics Revenue

Stoke Therapeutics had revenue of $10.63M in the quarter ending September 30, 2025, with 117.25% growth. This brings the company's revenue in the last twelve months to $205.63M, up 1,128.17% year-over-year. In the year 2024, Stoke Therapeutics had annual revenue of $36.56M with 316.34% growth.

Revenue (ttm)
$205.63M
Revenue Growth
+1,128.17%
P/S Ratio
10.64
Revenue / Employee
$1,606,500
Employees
128
Market Cap
2.19B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202436.56M27.78M316.34%
Dec 31, 20238.78M-3.63M-29.22%
Dec 31, 202212.41M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Galapagos NV 1.31B
Ultragenyx Pharmaceutical 673.00M
Aurinia Pharmaceuticals 283.06M
Iovance Biotherapeutics 263.50M
Soleno Therapeutics 190.41M
Syndax Pharmaceuticals 172.35M
Mesoblast 65.38M
Nektar Therapeutics 62.60M
Revenue Rankings

STOK News

More News